Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators
Samuel K. Estabrooks, Jeffrey L. Brodsky
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 452-452
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Pharmacological targeting of endoplasmic reticulum stress in disease
Stefan J. Marciniak, Joseph E. Chambers, David Ron
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 2, pp. 115-140
Closed Access | Times Cited: 347
An intramembrane chaperone complex facilitates membrane protein biogenesis
Patrick J. Chitwood, Ramanujan S. Hegde
Nature (2020) Vol. 584, Iss. 7822, pp. 630-634
Open Access | Times Cited: 88
Functional Consequences of CFTR Interactions in Cystic Fibrosis
Yashaswini Ramananda, Anjaparavanda P. Naren, Kavisha Arora
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3384-3384
Open Access | Times Cited: 11
Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR
Nesrine Baatallah, Ahmad Elbahnsi, Jean‐Paul Mornon, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 23, pp. 7813-7829
Open Access | Times Cited: 48
Choice of Differentiation Media Significantly Impacts Cell Lineage and Response to CFTR Modulators in Fully Differentiated Primary Cultures of Cystic Fibrosis Human Airway Epithelial Cells
Vinciane Saint‐Criq, Livia Delpiano, John Casement, et al.
Cells (2020) Vol. 9, Iss. 9, pp. 2137-2137
Open Access | Times Cited: 46
Elexacaftor/VX-445–mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics
Minsoo Kim, Eli Fritz McDonald, Carleen Mae P. Sabusap, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 10, pp. 105242-105242
Open Access | Times Cited: 16
Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations
Garrett Pehote, Neeraj Vij
Cells (2020) Vol. 9, Iss. 9, pp. 1952-1952
Open Access | Times Cited: 35
Cystic Fibrosis: A Journey through Time and Hope
Pascal Trouvé, Aude Saint Pierre, Claude Férec
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9599-9599
Open Access | Times Cited: 4
The Distribution and Role of the CFTR Protein in the Intracellular Compartments
Agnieszka Łukasiak, Mirosław Zając
Membranes (2021) Vol. 11, Iss. 11, pp. 804-804
Open Access | Times Cited: 24
Comprehensive survey of disease-causing missense mutations of the cholesterol synthesis enzyme NSDHL: Low temperature and a chemical chaperone rescue low protein expression of select mutants
Nicole Fenton, Laura J. Sharpe, Daniel Fitzsimmons, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2025), pp. 106758-106758
Open Access
Impact of ER stress and the unfolded protein response on Fabry disease
Malte Lenders, E. Tanzi Rudolph, Eva Brand
EBioMedicine (2025) Vol. 115, pp. 105733-105733
Open Access
Current Treatment Options for Cystic Fibrosis-Related Liver Disease
Katharina Staufer
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8586-8586
Open Access | Times Cited: 27
Cystic Fibrosis: Understanding Cystic Fibrosis Transmembrane Regulator Mutation Classification and Modulator Therapies
Saba Anwar, Jingliang Peng, Kashif Rafiq Zahid, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 4, pp. 263-277
Open Access | Times Cited: 3
Immunomodulation in Cystic Fibrosis: Why and How?
Vincent D. Giacalone, Brian Dobosh, Amit Gaggar, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3331-3331
Open Access | Times Cited: 21
Revisiting CFTR Interactions: Old Partners and New Players
Carlos M. Farinha, Martina Gentzsch
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13196-13196
Open Access | Times Cited: 18
Elexacaftor/VX-445-mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics
Minsoo Kim, Eli Fritz McDonald, Carleen Mae P. Sabusap, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
GJB4 variants linked to skin disease exhibit a trafficking deficiency en route to gap junction formation that can be restored by co-expression of select connexins
Sergiu A. Lucaciu, Rhett Figliuzzi, Ruth Neumann, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 7
New Therapies to Correct the Cystic Fibrosis Basic Defect
Christelle Bergeron, André M. Cantin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6193-6193
Open Access | Times Cited: 15
Endoplasmic Reticulum Associated Protein Degradation (ERAD) in the Pathology of Diseases Related to TGFβ Signaling Pathway: Future Therapeutic Perspectives
Nesrin Gariballa, Bassam R. Ali
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 16
Improved correction of F508del-CFTR biogenesis with a folding facilitator and an inhibitor of protein ubiquitination
Jennifer L. Goeckeler-Fried, R. Aldrin Denny, Disha Joshi, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 48, pp. 128243-128243
Open Access | Times Cited: 12
CFTR Modulator Therapy for Rare CFTR Mutants
Marco Mergiotti, Alessandra Murabito, Giulia Prono, et al.
Journal of Respiration (2022) Vol. 2, Iss. 2, pp. 59-76
Open Access | Times Cited: 9
How to determine the mechanism of action of CFTR modulator compounds: A gateway to theranostics
Margarida D. Amaral
European Journal of Medicinal Chemistry (2020) Vol. 210, pp. 112989-112989
Closed Access | Times Cited: 12
Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters
B. Chevalier, Nesrine Baatallah, Matthieu Najm, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8937-8937
Open Access | Times Cited: 8
CyFi-MAP: an interactive pathway-based resource for cystic fibrosis
Catarina Pereira, Alexander Mazein, Carlos M. Farinha, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 10
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant
Christian Borgo, Claudio D’Amore, Valeria Capurro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2302-2302
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top